Kenneth S. Bauer

2.2k total citations
39 papers, 1.7k citations indexed

About

Kenneth S. Bauer is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Kenneth S. Bauer has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Kenneth S. Bauer's work include Cancer Treatment and Pharmacology (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Kenneth S. Bauer is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Kenneth S. Bauer collaborates with scholars based in United States, Malaysia and United Kingdom. Kenneth S. Bauer's co-authors include Shannon C. Dixon, William D. Figg, William D. Figg, Suhlan Wu, Richard M. Lush, Edward A. Sausville, Susan E. Krown, Jeannette Y. Lee, David M. Aboulafia and Bruce J. Dezube and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kenneth S. Bauer

39 papers receiving 1.7k citations

Peers

Countries citing papers authored by Kenneth S. Bauer

Since Specialization

Citations

This map shows the geographic impact of Kenneth S. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth S. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth S. Bauer more than expected).

Fields of papers citing papers by Kenneth S. Bauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth S. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth S. Bauer. The network helps show where Kenneth S. Bauer may publish in the future.

Co-authorship network of co-authors of Kenneth S. Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth S. Bauer. A scholar is included among the top collaborators of Kenneth S. Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth S. Bauer. Kenneth S. Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Durvalumab: a newly approved checkpoint inhibitor for the treatment of urothelial carcinoma 2018 ·Current Problems in Cancer ·(unknown), (unknown), Kenneth S. Bauer, Rahul R. Deshmukh	11
2	Simultaneous determination of l-tetrahydropalmatine and cocaine in human plasma by simple UPLC–FLD method: Application in clinical studies 2014 ·Journal of Chromatography B ·Mingming Yu, Hazem E. Hassan, (unknown), Kenneth S. Bauer, Deanna L. Kelly, Jia Bei Wang	18
3	Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome 2013 ·Investigational New Drugs ·Ivana Gojo, Alexander E. Perl, Selina M. Luger, Maria R. Baer, Kelly J. Norsworthy, Kenneth S. Bauer, Michael Tidwell, (unknown), Martin Carroll, Edward A. Sausville	42
4	Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine 2011 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Karthika Natarajan, Yi Xie, Takeo Nakanishi, William T. Beck, Kenneth S. Bauer, Douglas D. Ross	15
5	Comparison of Two Nitroxide Labile Esters for Delivering Electron Paramagnetic Resonance Probes into Mouse Brain 2010 ·Journal of Pharmaceutical Sciences ·Minoru Miyake, Scott R. Burks, John Weaver, Pei Tsai, Wenlan Liu, David I. Bigio, Kenneth S. Bauer, Ke Jian Liu, Gerald M. Rosen, Joseph P. Y. Kao	10
6	Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes 2009 ·Chemico-Biological Interactions ·(unknown), Kenneth S. Bauer, Alexander Zakharov, Judith M. Hill, (unknown), Brian F. Thomas, Arthur G. Schwartz, Izet M. Kapetanović, Alexander V. Lyubimov	6
7	Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats 2008 ·Chemico-Biological Interactions ·Izet M. Kapetanović, Kenneth S. Bauer, Daniel Tessier, (unknown), Alexander Zakharov, Ronald A. Lubet, Alexander V. Lyubimov	17
8	A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia 2004 ·Leukemia Research ·Kenneth S. Bauer, Judith E. Karp, Τushar Garimella, Suhlan Wu, Ming Tan, Douglas D. Ross	19
9	Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors 2004 ·Cancer Chemotherapy and Pharmacology ·Τushar Garimella, D D Ross, Julie L. Eiseman, John Mondick, Erin Joseph, Takeo Nakanishi, Susan E. Bates, Kenneth S. Bauer	14
10	Liquid chromatography method for the quantitation of the breast cancer resistance protein ABCG2 inhibitor fumitremorgin C and its chemical analogues in mouse plasma and tissues 2004 ·Journal of Chromatography B ·Τushar Garimella, Douglas D. Ross, Kenneth S. Bauer	10
11	Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug 2003 ·Cancer Chemotherapy and Pharmacology ·Martin J. Edelman, Kenneth S. Bauer, (unknown), Nancy Tait, Jane B. Trepel, Judith E. Karp, (unknown), (unknown), David Van Echo	72
12	Functional Characterization of Human Breast Cancer Resistance Protein (BCRP, ABCG2) Expressed in the Oocytes of Xenopus laevis 2003 ·Molecular Pharmacology ·Takeo Nakanishi, L. Austin Doyle, Bret A. Hassel, (unknown), Kenneth S. Bauer, Suhlan Wu, David W. Pumplin, Hong‐Bin Fang, Douglas D. Ross	65
13	Preclinical evaluation of the pharmacokinetics, brain uptake and metabolism of E121, an antiepileptic enaminone ester, in rats 2003 ·Biopharmaceutics & Drug Disposition ·(unknown), Noha N. Salama, Kenneth R. Scott, (unknown), Kenneth S. Bauer, Natalie D. Eddington	16
14	Clinical Pharmacology of Flavopiridol following a 72-Hour Continuous Infusion 2003 ·Annals of Pharmacotherapy ·Michelle A. Rudek, Kenneth S. Bauer, Richard M. Lush, Sherman F. Stinson, Adrian M. Senderowicz, Donna Headlee, Susan G. Arbuck, Michael C. Cox, Anthony J. Murgo, Edward A. Sausville, William D. Figg	36
15	High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma 2000 ·Journal of Pharmaceutical and Biomedical Analysis ·Michelle A. Rudek, Clark March, Kenneth S. Bauer, James M. Pluda, William D. Figg	19
16	A molecular analysis of ground sloth diet through the last glaciation 2000 ·Molecular Ecology ·Michael Hofreiter, Hendrik N. Poinar, W. Geoffrey Spaulding, Kenneth S. Bauer, Paul S. Martin, Göran Possnert, Svante Pääbo	146
17	Pharmacokinetics of thalidomide in an elderly prostate cancer population 1999 ·Journal of Pharmaceutical Sciences ·William D. Figg, Sangeeta Raje, Kenneth S. Bauer, A Tompkins, David Venzon, Raymond C. Bergan, Alice P. Chen, Michael Hamilton, James M. Pluda, Eddie Reed	106
18	A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer. 1999 ·PubMed ·Kenneth S. Bauer, William D. Figg, (unknown), (unknown), A Premkumar, S. M. Steinberg, (unknown), W. Marston Linehan, James M. Pluda, E Reed	49
19	Do Alprazolam‐Induced Changes in Saccadic Eye Movement and Psychomotor Function Follow the Same Time Course? 1998 ·The Journal of Clinical Pharmacology ·Patricia D. Kroboth, (unknown), Kenneth S. Bauer, (unknown), Caroline Wright, John A. Sweeney	13
20	Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations. 1997 ·Journal of Clinical Oncology ·Elise C. Kohn, William D. Figg, Gisele Sarosy, Kenneth S. Bauer, Patricia Anne Davis, M. Soltis, (unknown), Lance A. Liotta, E Reed	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact